Welcome Prof. Vittorio Silingardi University of Modena, Italy   Good morning ladies and gentlemen. I'm very glad to welcome all the Foreign and Italian researchers that have come here today to discuss Monoclonal Antibody Therapies for Hematological Malignancies, specifically on B lymphomas and on acute myeloid leukemia.